2022
DOI: 10.15252/emmm.202216489
|View full text |Cite
|
Sign up to set email alerts
|

Targeting CRAC channels in inflammatory bowel disease

Abstract: Inflammatory bowel disease (IBD) is a collective term for inflammatory diseases of the human gastrointestinal (GI) tract that are characterized by perturbations in the intestinal immune responses. In their study, Letizia et al (2022) found an enrichment of CD4+ effector T cells, interferon gamma (IFNγ) producing CD8+ T cells, regulatory T cells, and innate lymphoid cells (ILC) in the lamina propria (LP) of IBD patients. In these cells, pharmacological inhibition of store‐operated calcium entry (SOCE) reduced c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…Abnormal functioning of CRACs has been linked to severe combined immunodeficiency and various other medical conditions, including allergies, atherosclerosis, and inflammatory bowel disease. Additionally, CRACs reportedly influence cancer cell proliferation and metastasis [7][8][9][10][11]. Accordingly, increased attention has been focused on substances that can modulate the activity of these channels [12].…”
Section: Introductionmentioning
confidence: 99%
“…Abnormal functioning of CRACs has been linked to severe combined immunodeficiency and various other medical conditions, including allergies, atherosclerosis, and inflammatory bowel disease. Additionally, CRACs reportedly influence cancer cell proliferation and metastasis [7][8][9][10][11]. Accordingly, increased attention has been focused on substances that can modulate the activity of these channels [12].…”
Section: Introductionmentioning
confidence: 99%